9136 Erlotinib as a second-line therapy in advanced non...

European Journal of Cancer Supplements 2009 / 9 Vol. 7; Iss. 2

9136 Erlotinib as a second-line therapy in advanced non small cell lung cancer: correlation between clinical characteristics and biomarkers

Rotella, V., Mazzoni, F., Pratesi, N., Simi, L., Orlando, C., Boni, L., Comin, C.E., Maddau, C., Costanzo, F. Di
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71849-X
Date:
September, 2009
File:
PDF, 47 KB
english, 2009
Conversion to is in progress
Conversion to is failed